$12.86
0.554.47%
Last update: Oct 29, 10:37 AM
MoonLake Immunotherapeutics
MLTXNASDAQ
MoonLake (MLTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.90 | $-0.90 | $-0.99 | $-0.91 |
| Actual | $-0.84 | $-0.98 | $-0.92 | $-1.10 |
| Surprise | +6.67% | -8.89% | +7.07% | -20.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.78 | $-0.81 | $-0.63 | $-0.72 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.84 | $-0.90 | 6.67 % |
| Q1 | May 11, 2026 | $-0.98 | $-0.90 | -8.89 % |
| Q4 | Feb 25, 2026 | $-0.92 | $-0.99 | 7.07 % |
| Q3 | Nov 5, 2025 | $-1.10 | $-0.91 | -20.9 % |
